Veracyte, Inc.
$1.3K 62 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
IntrinsiQ Specialty Solutions, Inc.
IntrinsiQ Specialty Solutions, Inc. reported $1,265.48 across General Payments, Research, and Ownership to 17 physicians and teaching hospitals across 17 transactions.
- $1.3K Below-median payer
- All-tracks total
- 17 Below-median volume
- Transactions
- 17 Below-median reach
- Recipients
- +$449.44
- General Payments vs PY2023
IntrinsiQ Specialty Solutions, Inc. reported $1,265.48 across all CMS Open Payments tracks (General + Research + Ownership) to 17 physicians and teaching hospitals in Program Year 2024 - ranking #1830 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,265.48, averaging $74.44 per recipient.
IntrinsiQ Specialty Solutions, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer intrinsiq-specialty-solutions-inc IntrinsiQ Specialty Solutions, Inc.
$1.3K · #1830/1,925 · 0.0% industry · PY2024
- TOT $1.3K
- RANK #1830
- SHARE 0.0%
- TXN 17
- RCP 17
- CAT 1
- GEN $1.3K
- ΔGEN +$449.44
- TOP1 14.6%
- PY 2024
Volume peers
Nearest volume peer: Veracyte, Inc. ($1.3K)
IntrinsiQ Specialty Solutions, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
IntrinsiQ Specialty Solutions, Inc.'s CMS-reported General Payments increased by $449.44 (+55.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: INTRINSIQ SPECIALTY SOLUTIONS, INC.PY2023: INTRINSIQ SPECIALTY SOLUTIONS, INC.PY2024: IntrinsiQ Specialty Solutions, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $816.04
- PY2024
- $1,265.48
What the Data Shows for IntrinsiQ Specialty Solutions, Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For IntrinsiQ Specialty Solutions, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
17 transactions worth $1.3K make "Food and Beverage" the top general-payment category in the 1-category breakdown below, 100.0% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 1 types of general payments, IntrinsiQ Specialty Solutions, Inc.'s largest category was "Food and Beverage" at $1.3K - 100.0% of General Payments.
How IntrinsiQ Specialty Solutions, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $1.3K | 17 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $753.97 (59.6%) of $1,265.48 in this company's General Payments records across 16 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for IntrinsiQ Specialty Solutions, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Norman Gaylis
$184.21 across 1 reported transactions
- 2
Julie a Keegan Strosser
$184.20 across 1 reported transactions
- 3
David Oubre
$165.37 across 1 reported transactions
- 4
John Kitchens
$114.83 across 2 reported transactions
- 5
Edward Cohen
$105.36 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
IntrinsiQ Specialty Solutions, Inc. ranks #1830 of 1,925 by total payments (bottom 5% by spend) but is notably more concentrated than that alone would suggest -- #1,057 of 1,838 by HHI (bottom 43% least concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- STRATA Skin Sciences, Inc. : $89.3K total payments, HHI 940
- Neptune Medical Inc. : $119.4K total payments, HHI 936
- Spirair, Inc. : $58.8K total payments, HHI 936
- Neoss, Inc. : $107.6K total payments, HHI 934
- Acist Medical Systems, Inc. : $163.3K total payments, HHI 931
- USA Angelalign Technology Corp : $100.0K total payments, HHI 930
- IntrinsiQ Specialty Solutions, Inc. (this company) : $1.3K total payments, HHI 926
- Precision Medical Products Inc. : $832.29 total payments, HHI 924
- CPM Medical Consultants, LLC : $2.4K total payments, HHI 919
- Acessa Health Inc. : $767.2K total payments, HHI 919
- Ortho Development Corporation : $3.6M total payments, HHI 918
- EDW Pharma, Inc. : $2.6K total payments, HHI 916
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as IntrinsiQ Specialty Solutions, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about IntrinsiQ Specialty Solutions, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with IntrinsiQ Specialty Solutions, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Dash Medical Gloves LLC
$1.2K 35 recipients
Compare payment profiles
Advanced Critical Devices, Inc.
$1.2K 23 recipients
Compare payment profiles
Nsk America Corporation
$1.2K 20 recipients
Compare payment profiles
Dimension Inx Corp
$1.2K 2 recipients
Compare payment profiles
Lazarus 3D
$1.2K 14 recipients
Compare payment profiles
Put this to use
IntrinsiQ Specialty Solutions, Inc. ranks #1830 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just IntrinsiQ Specialty Solutions, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.